55 related articles for article (PubMed ID: 24854571)
1. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells.
Wang Y; Yang C; Xie WL; Zhao YW; Li ZM; Sun WJ; Li LZ
Phytomedicine; 2014; 21(8-9):1032-6. PubMed ID: 24854571
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydroxystilbene Glucoside Regulates Proliferation, Differentiation, and OPG/RANKL/M-CSF Expression in MC3T3-E1 Cells via the PI3K/Akt Pathway.
Fan YS; Li Q; Hamdan N; Bian YF; Zhuang S; Fan K; Liu ZJ
Molecules; 2018 Sep; 23(9):. PubMed ID: 30201908
[TBL] [Abstract][Full Text] [Related]
3. Osteoblasts play key roles in the mechanisms of action of strontium ranelate.
Brennan TC; Rybchyn MS; Green W; Atwa S; Conigrave AD; Mason RS
Br J Pharmacol; 2009 Aug; 157(7):1291-300. PubMed ID: 19563530
[TBL] [Abstract][Full Text] [Related]
4. Bone destruction in chronic otitis media is not mediated by the RANKL pathway or estrogen receptor-alpha.
Heo KW; Noh M; Hur DY; Hong TU; Park SY; Kim WJ
Sci Prog; 2023; 106(3):368504231199204. PubMed ID: 37697808
[TBL] [Abstract][Full Text] [Related]
5. Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells.
Streicher C; Heyny A; Andrukhova O; Haigl B; Slavic S; Schüler C; Kollmann K; Kantner I; Sexl V; Kleiter M; Hofbauer LC; Kostenuik PJ; Erben RG
Sci Rep; 2017 Jul; 7(1):6460. PubMed ID: 28744019
[TBL] [Abstract][Full Text] [Related]
6. Puerarin blocks the aging phenotype in human dermal fibroblasts.
Kamiya Y; Odama M; Mizuguti A; Murakami S; Ito T
PLoS One; 2021; 16(4):e0249367. PubMed ID: 33886592
[TBL] [Abstract][Full Text] [Related]
7. Advances in Extraction, Purification, and Analysis Techniques of the Main Components of Kudzu Root: A Comprehensive Review.
Xuan T; Liu Y; Liu R; Liu S; Han J; Bai X; Wu J; Fan R
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764353
[TBL] [Abstract][Full Text] [Related]
8. Probiotic
Yeom J; Ma S; Lim YH
Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33805153
[TBL] [Abstract][Full Text] [Related]
9. Puerarin Delays Mammary Gland Aging by Regulating Gut Microbiota and Inhibiting the p38MAPK Signaling Pathway.
Liu S; Hu H; Zhang M; Zhang Y; Geng R; Jin Y; Cao Y; Guo W; Liu J; Fu S
J Agric Food Chem; 2024 May; 72(19):10879-10896. PubMed ID: 38686994
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine.
Zhang L
Drug Deliv; 2019 Dec; 26(1):860-869. PubMed ID: 31524010
[No Abstract] [Full Text] [Related]
11. Pueraria lobata-derived exosome-like nanovesicles alleviate osteoporosis by enhacning autophagy.
Zhan W; Deng M; Huang X; Xie D; Gao X; Chen J; Shi Z; Lu J; Lin H; Li P
J Control Release; 2023 Dec; 364():644-653. PubMed ID: 37967723
[TBL] [Abstract][Full Text] [Related]
12. Lignin/Puerarin Nanoparticle-Incorporated Hydrogel Improves Angiogenesis through Puerarin-Induced Autophagy Activation.
Pan Y; Lin T; Shao L; Zhang Y; Han Q; Sheng L; Guo R; Sun T; Zhang Y
Int J Nanomedicine; 2023; 18():5095-5117. PubMed ID: 37705868
[TBL] [Abstract][Full Text] [Related]
13. Integrated Metabolomic and Transcriptomic Analysis of Puerarin Biosynthesis in
Hu X; Zhu T; Min X; He J; Hou C; Liu X
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137052
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.
Kang JH; Ko HM; Moon JS; Yoo HI; Jung JY; Kim MS; Koh JT; Kim WJ; Kim SH
J Dent Res; 2014 Nov; 93(11):1116-23. PubMed ID: 25256714
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy and Safety of Multiple Dose Regimens of Kudzu (
Bihlet AR; Byrjalsen I; Andersen JR; Simonsen SF; Mundbjerg K; Helmer B; Riis BJ; Karsdal MA; Christiansen C
Front Pharmacol; 2021; 12():760629. PubMed ID: 34744740
[No Abstract] [Full Text] [Related]
16. Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway.
Tang W; Xiao L; Ge G; Zhong M; Zhu J; Qin J; Feng C; Zhang W; Bai J; Zhu X; Wei M; Geng D; Wang Z
J Cell Mol Med; 2020 Oct; 24(20):11972-11983. PubMed ID: 32896108
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis.
He J; Li X; Wang Z; Bennett S; Chen K; Xiao Z; Zhan J; Chen S; Hou Y; Chen J; Wang S; Xu J; Lin D
Front Pharmacol; 2019; 10():1344. PubMed ID: 31824310
[TBL] [Abstract][Full Text] [Related]
18. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
Zhang G; Wang Y; Tang G; Ma Y
BMC Complement Altern Med; 2019 Oct; 19(1):269. PubMed ID: 31615565
[TBL] [Abstract][Full Text] [Related]
19. Puerarin promotes the proliferation and differentiation of MC3T3-E1 cells via microRNA-106b by targeting receptor activator of nuclear factor-κB ligand.
Shan Z; Cheng N; Huang R; Zhao B; Zhou Y
Exp Ther Med; 2018 Jan; 15(1):55-60. PubMed ID: 29375675
[TBL] [Abstract][Full Text] [Related]
20. Molecular signaling mechanisms behind polyphenol-induced bone anabolism.
Torre E
Phytochem Rev; 2017; 16(6):1183-1226. PubMed ID: 29200988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
